Iopamidol

CHEMBL1200932 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
777.1 g/mol
LogP
-2.4
Phase
4

This non-ionic iodinated contrast medium is used for cardiovascular angiography, CT imaging, urography, and myelography. Its low osmolality minimizes cardiovascular effects and patient discomfort during administration. Kidney function and allergy history should be assessed before use.

Berat Molekul

777,1000 g/mol

LogP

-2,40

TPSA

188,00 Ų

Lipinski RO5

Gagal

Area Terapeutik

Mekanisme Kerja

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I

InChI

InChI=1S/C17H22I3N3O8/c1-6(28)15(29)23-14-12(19)9(16(30)21-7(2-24)3-25)11(18)10(13(14)20)17(31)22-8(4-26)5-27/h6-8,24-28H,2-5H2,1H3,(H,21,30)(H,22,31)(H,23,29)/t6-/m0/s1

Molecular Formula

C17H22I3N3O8

HBD / HBA

8 / 8

Ikatan yang Dapat Dirotasi

10

Atom Berat

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This non-ionic iodinated contrast medium is used for cardiovascular angiography, CT imaging, urography, and myelography. Its low osmolality minimizes cardiovascular effects and patient discomfort during administration. Kidney function and allergy history should be assessed before use.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Iopamidol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200932. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 65492. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.